First Manhattan’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $377M | Sell |
767,160
-1,750
| -0.2% | -$950K | 1.05% | 23 |
|
|
2025
Q4 | $446M | Sell |
768,910
-6,270
| -0.8% | -$3.55M | 1.17% | 19 |
|
|
2025
Q3 | $376M | Sell |
775,180
-181,524
| -19% | -$84.5M | 0.99% | 22 |
|
|
2025
Q2 | $388M | Buy |
956,704
+8,141
| +0.9% | +$3.4M | 1.1% | 19 |
|
|
2025
Q1 | $472M | Buy |
948,563
+57,242
| +6% | +$31M | 1.38% | 12 |
|
|
2024
Q4 | $464M | Buy |
891,321
+4,991
| +0.6% | +$2.74M | 1.36% | 14 |
|
|
2024
Q3 | $549M | Sell |
886,330
-19,302
| -2% | -$11.4M | 1.63% | 11 |
|
|
2024
Q2 | $501M | Sell |
905,632
-7,885
| -0.9% | -$4.52M | 1.61% | 12 |
|
|
2024
Q1 | $531M | Sell |
913,517
-4,294
| -0.5% | -$2.41M | 1.72% | 11 |
|
|
2023
Q4 | $485M | Sell |
917,811
-102,628
| -10% | -$49.7M | 1.68% | 12 |
|
|
2023
Q3 | $515M | Buy |
1,020,439
+58,734
| +6% | +$31.3M | 1.9% | 12 |
|
|
2023
Q2 | $500M | Buy |
961,705
+236,861
| +33% | +$128M | 1.83% | 11 |
|
|
2023
Q1 | $418M | Buy |
724,844
+72,792
| +11% | +$41M | 1.6% | 13 |
|
|
2022
Q4 | $359M | Buy |
652,052
+13,055
| +2% | +$6.92M | 1.32% | 12 |
|
|
2022
Q3 | $323M | Sell |
638,997
-4,474
| -0.7% | -$2.5M | 1.37% | 12 |
|
|
2022
Q2 | $348M | Buy |
643,471
+12,837
| +2% | +$7.07M | 1.4% | 12 |
|
|
2022
Q1 | $372M | Sell |
630,634
-4,491
| -0.7% | -$2.58M | 1.22% | 14 |
|
|
2021
Q4 | $424M | Sell |
635,125
-2,780
| -0.4% | -$1.74M | 1.4% | 14 |
|
|
2021
Q3 | $364M | Buy |
637,905
+2,789
| +0.4% | +$1.53M | 1.34% | 15 |
|
|
2021
Q2 | $320M | Buy |
635,116
+90,345
| +17% | +$42.6M | 1.17% | 16 |
|
|
2021
Q1 | $249M | Buy |
544,771
+1,922
| +0.4% | +$917K | 1.07% | 18 |
|
|
2020
Q4 | $253M | Sell |
542,849
-9,896
| -2% | -$4.64M | 1.21% | 17 |
|
|
2020
Q3 | $244M | Buy |
552,745
+13,834
| +3% | +$5.72M | 1.26% | 13 |
|
|
2020
Q2 | $195M | Sell |
538,911
-17,342
| -3% | -$5.81M | 1.13% | 17 |
|
|
2020
Q1 | $158M | Sell |
556,253
-4,702
| -0.8% | -$1.48M | 1.02% | 15 |
|
|
2019
Q4 | $182M | Sell |
560,955
-7,069
| -1% | -$2.14M | 0.91% | 20 |
|
|
2019
Q3 | $165M | Sell |
568,024
-181
| -0% | -$51.8K | 0.91% | 19 |
|
|
2019
Q2 | $167M | Buy |
568,205
+60,829
| +12% | +$16.8M | 0.93% | 18 |
|
|
2019
Q1 | $139M | Buy |
507,376
+18,184
| +4% | +$4.53M | 0.8% | 25 |
|
|
2018
Q4 | $109M | Sell |
489,192
-12,370
| -2% | -$2.9M | 0.68% | 27 |
|
|
2018
Q3 | $122M | Sell |
501,562
-7,253
| -1% | -$1.67M | 0.65% | 28 |
|
|
2018
Q2 | $105M | Sell |
508,815
-7,483
| -1% | -$1.59M | 0.61% | 30 |
|
|
2018
Q1 | $107M | Sell |
516,298
-13,398
| -3% | -$2.81M | 0.61% | 27 |
|
|
2017
Q4 | $101M | Sell |
529,696
-2,419
| -0.5% | -$463K | 0.55% | 29 |
|
|
2017
Q3 | $101M | Sell |
532,115
-1,726
| -0.3% | -$313K | 0.58% | 29 |
|
|
2017
Q2 | $93.1M | Sell |
533,841
-6,540
| -1% | -$1.1M | 0.54% | 33 |
|
|
2017
Q1 | $83M | Sell |
540,381
-76,957
| -12% | -$11.8M | 0.49% | 38 |
|
|
2016
Q4 | $87.1M | Sell |
617,338
-3,084
| -0.5% | -$455K | 0.53% | 35 |
|
|
2016
Q3 | $98.7M | Buy |
620,422
+1,245
| +0.2% | +$192K | 0.6% | 32 |
|
|
2016
Q2 | $91.5M | Buy |
619,177
+17,375
| +3% | +$2.56M | 0.56% | 32 |
|
|
2016
Q1 | $85.2M | Buy |
601,802
+183,070
| +44% | +$24.5M | 0.52% | 37 |
|
|
2015
Q4 | $59.4M | Buy |
418,732
+417,650
| +38,600% | +$55.7M | 0.36% | 51 |
|
|
2015
Q3 | $132K | Hold |
1,082
| – | – | ﹤0.01% | 751 |
|
|
2015
Q2 | $140K | Hold |
1,082
| – | – | ﹤0.01% | 763 |
|
|
2015
Q1 | $145K | Sell |
1,082
-750
| -41% | -$96.7K | ﹤0.01% | 760 |
|
|
2014
Q4 | $229K | Buy |
1,832
+750
| +69% | +$91.2K | ﹤0.01% | 674 |
|
|
2014
Q3 | $131K | Hold |
1,082
| – | – | ﹤0.01% | 765 |
|
|
2014
Q2 | $127K | Sell |
1,082
-490
| -31% | -$57.7K | ﹤0.01% | 769 |
|
|
2014
Q1 | $189K | Buy |
1,572
+9
| +0.6% | +$1.07K | ﹤0.01% | 682 |
|
|
2013
Q4 | $174K | Buy |
1,563
+433
| +38% | +$43.1K | ﹤0.01% | 694 |
|
|
2013
Q3 | $104K | Hold |
1,130
| – | – | ﹤0.01% | 780 |
|
|
2013
Q2 | $102K | Buy |
+1,130
| New | +$94.1K | ﹤0.01% | 783 |
|
Other funds holding TMO
VCM
First Manhattan's TMO Position: Q1 2026 in Review
First Manhattan reduced its Thermo Fisher Scientific (TMO) stake by 0.23% in Q1 2026, selling an estimated $950K and leaving 767,160 shares worth $377M. The position accounts for 1.05% of the portfolio, ranked #23.
First Manhattan first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $549M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- First Manhattan held 767,160 shares of Thermo Fisher Scientific worth $377M as of Q1 2026.
- First Manhattan sold 1,750 Thermo Fisher Scientific shares in Q1 2026, an estimated $950K.
- Thermo Fisher Scientific made up 1.05% of First Manhattan's portfolio in Q1 2026, its #23 holding.
- First Manhattan first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- First Manhattan's Thermo Fisher Scientific position peaked at $549M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.